semaglutide autoimmune Disease and Ozempic: Safety and Considerations GLP1 microdosing for autoimmune conditions?

Santos, a doctor the recipient does not know

Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RA) have shown promising effects on heart failure (HF) outcomes, particularly in phenotype-specific populations

Treatment with liraglutide was shown to modulate the diversity of the gut microbiota in experiments conducted on animals on a high-fat diet [113, 114]

Second, we performed sensitivity analyses excluding those with low MPR (selected thresholds are described previously in the section Exposure) in either metformin or study drug (GLP-1 RA or DPP-4i) during the study period

27, 2025, the FDA approved the first generic version of liraglutide (Saxenda) for weight loss in adults and adolescents with obesity and adults with overweight and at least one weight-related comorbid condition